Myomo Inc - רווח למניה ב-12 החודשים האחרונים MYO

Geopolitical instability and logistics disruptions are limiting the export of Myomo, Inc. (MYO) exoskeletons to foreign markets. The EPS YoY growth rate (trailing 12 months) illustrates these challenges alongside operating losses and insurance reimbursement issues. The current -22.20 determines the magnitude of the profit metric. Meanwhile, the expansion of MyoPro direct sales channels is reducing the cost of goods sold, creating significant leverage for margin growth.
Myomo - פילוחים אנליטיים ומדדי מפתח (MYO)

For a comparative asset analysis, the investor utilizes this indicator as a measure of a single stock's real return dynamics over a rolling year, which neutralizes the impact of random financial fluctuations. The commercialization efficiency of orthopedic systems and the transparency of Medicare operations at Myomo, Inc. (MYO) directly determine the trend of the net income per share (ttm) annual growth rate, reflecting the fundamental resilience of the business.